Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,943,794 papers from all fields of science
Search
Sign In
Create Free Account
dianhydro-3,4-diacetylgalactitol
Known as:
diacetyl-diepoxydulcitol
, diacetyldianhydrodulcitol
, diacetyldianhydrogalactitol
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Dianhydrogalactitol
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol…
丹尼斯·M·布朗
,
杰佛利A·巴察
,
威廉·J·加纳
2013
Corpus ID: 140367775
Methods and compositions suitable for the treatment of malignancies in subjects with a germline deletion polymorphism that blocks…
Expand
2011
2011
Inhibitory effect of diacetyldianhydrogalactitol on transplanted hepatocarcinoma 22 growth and angiogenesis in mice
Cui Jing-rong
2011
Corpus ID: 87579044
Objective: To explore the anti-tumor and anti-angiogenesis effect of diacetyldianhydrogalactitol(DADAG) on hepatocarcinoma H22 in…
Expand
2009
2009
Inhibition of Diacetyldianhydrogalactitol on Ornithine Decarboxylase Activity and Its Possible Mechanisms
Cui Jing-rong
2009
Corpus ID: 88341554
OBJECTIVE We explored the effects of diacetyldianhydrogalac- titol (DADAG) on ornithine decarboxylase (ODC) activity and the…
Expand
2009
2009
Anticancer activity and mechanisms of diacetyldianhydrogalactitol on hepatoma QGY-7703 cells
Xue Zhang
,
Xue Lian Yan
,
+4 authors
Jing Rong Cui
Anti-Cancer Drugs
2009
Corpus ID: 1435516
Diacetyldianhydrogalactitol (DADAG) is a member of the hexitols which shows a significant anticancer effect. Despite the fact…
Expand
2006
2006
Inhibitory effect of diacetyldianhydrogalactitol on cells proliferation of leukemic L1210
Xue Jian-gong
2006
Corpus ID: 87444532
OBJECTIVE To evaluate the inhibitory effect of Dadag(diacetyldianhydrogalactitol) in mouse leukemic L1210 cells and explore its…
Expand
2004
2004
Pharmacokinetic study in a phase I trial with an alkylating agent, diacetyldianhydrogalactitol (DADAG)
V. Erdélyi-Tóth
,
S. Kerpel-Fronius
,
B. Kanyár
,
S. Eckhardt
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 28943951
SummaryDiacetyldianhydrogalactitol (DADAG), a new alkylating hexitol derivative, was given in 30-min infusions for 5 consecutive…
Expand
2004
2004
Relation between dose, plasma concentration and toxicity in a phase I trial using high dose intermittent administration of an alkylating agent, diacetyldianhydrogalactitol (DADAG)
S. Kerpel-Fronius
,
V. Erdélyi-Tóth
,
+8 authors
S. Eckhardt
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 21336754
SummaryDiacetyldianhydrogalactitol (DADAG), a new alkylating sugar alcohol derivative, was administered as single, 30-min…
Expand
2004
2004
The role of comparative pharmacokinetics in the planning of human dose escalation: the experience with diacetyldianhydrogalactitol
S. Kerpel-Fronius
,
V. Erdélyi-Tóth
,
+4 authors
B. Kanyár
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 23277530
SummaryThe pharmacokinetics of diacetyldianhydrogalactitol (DADAG) was compared in mice, rats, and humans. The ratios of human…
Expand
2002
2002
[Apoptosis induced by diacetyldianhydrogalactitol and its mechanism in HL-60 leukemia cells].
Jin-nan Yang
,
Ju-yuan Liu
,
Hua Xu
,
Xiao-li Liu
,
Yu Qin
Yao xue xue bao = Acta pharmaceutica Sinica
2002
Corpus ID: 33251356
AIM To investigate the apoptosis induced by diacetyldianhydrogalactitol (DADAG) and its mechanism in human HL-60 leukemia cells…
Expand
2002
2002
Experimental study of antitumor effect of diacetyldianhydrogalactitol on brain leukemia and its mechanism
Yang Jin-nan
2002
Corpus ID: 86986580
Objective To study the inhibitory effects of diacetyldianhydrogalactitol (DADAG) on brain leukemia and its mechanism. Method To…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE